Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 02, 2024

SELL
$74.43 - $92.22 $893 - $1,106
-12 Reduced 0.28%
4,213 $346,000
Q1 2024

May 08, 2024

BUY
$83.81 - $99.0 $91,604 - $108,207
1,093 Added 34.9%
4,225 $369,000
Q4 2023

Jan 19, 2024

BUY
$76.22 - $98.51 $31,936 - $41,275
419 Added 15.44%
3,132 $301,000
Q1 2022

May 05, 2022

SELL
$74.28 - $92.69 $23,918 - $29,846
-322 Reduced 10.61%
2,713 $209,000
Q4 2021

Feb 03, 2022

SELL
$71.72 - $91.47 $71 - $91
-1 Reduced 0.03%
3,035 $268,000
Q3 2021

Nov 04, 2021

SELL
$74.77 - $85.47 $5,532 - $6,324
-74 Reduced 2.38%
3,036 $235,000
Q2 2021

Aug 09, 2021

BUY
$75.51 - $84.79 $75 - $84
1 Added 0.03%
3,110 $259,000
Q1 2021

May 11, 2021

SELL
$74.73 - $90.69 $150,132 - $182,196
-2,009 Reduced 39.25%
3,109 $235,000
Q4 2020

Jan 27, 2021

SELL
$72.61 - $90.2 $12,053 - $14,973
-166 Reduced 3.14%
5,118 $449,000
Q3 2020

Nov 12, 2020

SELL
$71.87 - $131.03 $3,018 - $5,503
-42 Reduced 0.79%
5,284 $402,000
Q1 2020

May 07, 2020

SELL
$71.37 - $96.85 $15,130 - $20,532
-212 Reduced 3.83%
5,326 $450,000
Q4 2019

Jan 24, 2020

BUY
$64.27 - $86.37 $3,856 - $5,182
60 Added 1.1%
5,538 $468,000
Q3 2019

Oct 29, 2019

BUY
$67.4 - $85.11 $54,526 - $68,853
809 Added 17.33%
5,478 $369,000
Q2 2019

Jul 19, 2019

SELL
$80.35 - $93.9 $695,027 - $812,235
-8,650 Reduced 64.94%
4,669 $400,000
Q1 2019

Apr 24, 2019

BUY
$84.2 - $98.62 $86,473 - $101,282
1,027 Added 8.36%
13,319 $1.18 Million
Q4 2018

Jan 23, 2019

SELL
$80.14 - $106.07 $363,114 - $480,603
-4,531 Reduced 26.93%
12,292 $1.05 Million
Q3 2018

Oct 25, 2018

BUY
$93.92 - $105.72 $1.58 Million - $1.78 Million
16,823 New
16,823 $1.63 Million
Q2 2018

Aug 10, 2018

SELL
$76.01 - $99.03 $1.41 Million - $1.83 Million
-18,506 Closed
0 $0
Q1 2018

Apr 17, 2018

BUY
$77.67 - $92.63 $118,757 - $141,631
1,529 Added 9.01%
18,506 $1.5 Million
Q4 2017

Feb 01, 2018

SELL
$80.76 - $95.13 $123,482 - $145,453
-1,529 Reduced 8.26%
16,977 $1.51 Million
Q3 2017

Nov 09, 2017

BUY
$80.6 - $94.95 $1.49 Million - $1.76 Million
18,506
18,506 $1.72 Million

Others Institutions Holding BMRN

About BIOMARIN PHARMACEUTICAL INC


  • Ticker BMRN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 185,824,000
  • Market Cap $11.8B
  • Description
  • BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...
More about BMRN
Track This Portfolio

Track Jgp Global Gestao De Recursos Ltda. Portfolio

Follow Jgp Global Gestao De Recursos Ltda. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jgp Global Gestao De Recursos Ltda., based on Form 13F filings with the SEC.

News

Stay updated on Jgp Global Gestao De Recursos Ltda. with notifications on news.